Skip to main content
OpenTrials

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

1,103 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

NIPD on CFTC for Triplet Repeat Diseases

NCT03087526

Conditions
Ataxia, Basal Ganglia Diseases, Brain Diseases, +37 more
Locations
  • CHU Bordeaux Bordeaux, France
  • CHU Montpellier Montpellier, France
  • CHU Nice Nice, France
  • CHU Nîmes Nîmes, France
View Trial Details
Completed

TEsting METformin Against Cognitive Decline in HD

NCT04826692

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • Hospital Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitario Mare de Déu de la Mercé Barcelona, Spain
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

NCT05658510

Conditions
Aberrant Motor Behavior in Dementia, Agitation,Psychomotor, Behavior, +20 more
Locations
  • BioXcel Clinical Research Site 113 Bellflower, California, United States
  • BioXcel Clinical Research Site 128 Cerritos, California, United States
  • BioXcel Clinical Research Site 110 Culver City, California, United States
  • BioXcel Clinical Research Site 108 Garden Grove, California, United States
View all 24 locations
View Trial Details
Completed

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

NCT05107128

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Sage Investigational Site Little Rock, Arkansas, United States
  • Sage Investigational Site La Jolla, California, United States
  • Sage Investigational Site Los Angeles, California, United States
  • Sage Investigational Site Sacramento, California, United States
View all 49 locations
View Trial Details
Completed

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

NCT05358821

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Sage Investigational Site Birmingham, Alabama, United States
  • Sage Investigational Site Los Alamitos, California, United States
  • Sage Investigational Site Englewood, Colorado, United States
  • Sage Investigational Site Washington D.C., District of Columbia, United States
View all 14 locations
View Trial Details

Related conditions